You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGFR Tyrosine Kinase Inhibitors

Showing 1 - 25 of 7,719
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Stage IIIB~IV Trial in Taipei (Atezolizumab Injection; bevacizumab Injection)

Recruiting
  • NSCLC Stage IIIB~IV
  • Atezolizumab Injection; bevacizumab Injection
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 18, 2022

Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)

Recruiting
  • Non Small Cell Lung Cancer
  • Metformin Hydrochloride
  • Placebo
  • Mexico City, Mexico
    Instituto Nacional de Cancerologia
Jul 21, 2022

Osimertinib for Russian EGFR T790M Mutation-positive NSCLC

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Moscow, Russian Federation
      Federal State Budgetary Institution National Medical Research Ce
    Mar 29, 2022

    NSCLC With EGFR Mutation Trial in Mexico City (Glutamine plus L. reuteri)

    Recruiting
    • Non-Small Cell Lung Cancer With EGFR Mutation
    • Glutamine plus L. reuteri
    • Mexico City, Mexico
      Instituto Nacional de Cancerologia de Mexico
    May 2, 2023

    Carcinoma, Adenoid Cystic Trial in Qingdao (EGFR-TK Inhibitor)

    Recruiting
    • Carcinoma, Adenoid Cystic
    • EGFR-TK Inhibitor
    • Qingdao, Shandong, China
      Qingdao central Hospital
    Nov 1, 2021

    Lung Cancer, Lung Adenocarcinoma, EGFR Activating Mutation Trial in Vandoeuvre-lès-Nancy (Collection of surgical waste)

    Enrolling by invitation
    • Lung Cancer
    • +4 more
    • Collection of surgical waste
    • Vandoeuvre-lès-Nancy, Lorraine, France
      Seitlinger
    Nov 24, 2021

    Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged

    Withdrawn
    • Non-Small Cell Lung Cancer
    • InVisionFirst-Lung ctDNA assay
    • Los Angeles, California
    • +2 more
    Sep 16, 2022

    EGFR Mutant Advanced Non Small Cell Lung Cancer Trial in Australia, Taiwan (Tremelimumab, Durvalumab)

    Recruiting
    • EGFR Mutant Advanced Non Small Cell Lung Cancer
    • Bankstown, New South Wales, Australia
    • +17 more
    Sep 28, 2021

    Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

    Recruiting
    • Lung Neoplasm
    • +26 more
    • Boston, Massachusetts
    • +6 more
    Jun 23, 2022

    Bevacizumab Plus EGFR-TKIs in Chinese EGFR-mutant

    Recruiting
    • NSCLC
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Oct 17, 2020

    Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in United States (Laboratory Biomarker Analysis, Paclitaxel

    Completed
    Has Results
    • Recurrent Non-Small Cell Lung Carcinoma
    • Stage IV Non-Small Cell Lung Cancer
    • Laboratory Biomarker Analysis
    • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
    • Anchorage, Alaska
    • +11 more
    Jun 26, 2021

    Nsclc, EGFR Activating Mutation, EGF-R Positive NSCLC Trial in Hong Kong (Pembrolizumab, Lenvatinib, Pemetrexed)

    Recruiting
    • Nsclc
    • +5 more
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Nov 25, 2021

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Duarte, California
    • +14 more
    Jan 27, 2023

    NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • (no location specified)
    Mar 27, 2023

    Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

    Not yet recruiting
    • Tyrosine Kinase Inhibitors
    • Chronic Myeloid Leukemia
    • treatment of TKI in CML
    • Poitiers, France
      Chu Poitiers
    Feb 21, 2023

    Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
      • Rotterdam, Netherlands
        Erasmus MC
      Feb 2, 2022

      NSCLC With EGFR T790M Mutation, With Brain and/or Leptomeningeal Metastasis, Failed Tyrosine Kinase Inhibitors Trial in Seoul

      Active, not recruiting
      • Non-Small Cell Lung Cancer With EGFR T790M Mutation
      • +2 more
      • Seoul, Korea, Republic of
        Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
      Aug 8, 2021

      Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

      Not yet recruiting
      • Lung Cancer
      • Non Small Cell Lung Cancer
      • Amivantamab 1050mg
      • +2 more
      • Aurora, Colorado
      • +2 more
      Apr 25, 2023

      Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

      Recruiting
      • Lung Neoplasms
      • +23 more
      • La Jolla, California
      • +35 more
      Oct 6, 2022

      Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine

      Completed
      • Adenocarcinoma of Lung
      • +6 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Oct 15, 2020

        B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • +4 more
        • Non-Interventional Study
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Nov 22, 2023

        Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

        Recruiting
        • Atrial Fibrillation
        • +4 more
        • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
        • New Hyde Park, New York
          Northwell (Northshore University/Long Island Jewish Hospitals)
        Dec 1, 2022

        CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

        Recruiting
        • CML
        • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
        • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
          FUNDALEU
        Jun 29, 2023

        Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes

        Active, not recruiting
        • Patients Diagnosed as Chronic Meyloid Leukemia
        • Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
        • Assiut, Egypt
          Assiut University Hospital
        Feb 19, 2022

        r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

        Not yet recruiting
        • B-cell Lymphoma
        • Beijing, Beijing, China
          Deparment of Hematology, Peking University People's Hospital
        Aug 9, 2022